Kura Oncology, Inc. (KURA) short interest & options flow
NASDAQKura Oncology heads into its November 9 earnings report with short interest entrenched at an elevated level, options traders turning more defensive by the day, and a wide gap between where the stock trades and what the Street thinks it is worth. The clearest positioning signal right now is in the options market. Put/call ratio has climbed to 1.25, its highest reading of the past…
KURA cost to borrow surges to 0.43%, up 1,081% in a week from near-zero levels.
- Market cap
- $673M
- Next earnings
- 25 Feb 2027
Key data as of 11 Nov 2026

KURA news and analysis
RSSNo long-form analysis yet for KURA. Pulse alerts and the live data picture are available on ORTEX.
Open KURA on ORTEX →Want the live picture for KURA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KURA — free to start on ORTEX.
Sign up for free →Open KURA on ORTEX